Dermorphin
Dermorph
Dermorphin is a naturally occurring seven-amino acid opioid peptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) first isolated from the skin secretions of South American tree frogs of the genus Phyllomedusa. It is approximately 30-40 times more potent than morphine as a mu-opioid receptor agonist and contains the unusual D-alanine residue at position 2, making it one of the first discovered naturally occurring D-amino acid-containing peptides. It has gained notoriety for its illegal use in horse racing as a performance enhancer and pain masking agent.
作用机制
Naturally occurring heptapeptide isolated from the skin of South American tree frogs (Phyllomedusa). Potent and selective mu-opioid receptor agonist — approximately 30-40 times more potent than morphine. Contains D-alanine, which is rare in natural peptides.
研究协议
仅供研究使用,非医疗建议。
Not recommended for human research due to extreme potency and opioid receptor agonism. Primarily of academic interest. Studied in pharmacological research for understanding mu-opioid receptor selectivity.
研究笔记
Clinical Research Status
Dermorphin has not been developed for human clinical use and has no active clinical trials or regulatory filings for any therapeutic indication. Research has been confined to pharmacological characterization, opioid receptor binding studies, and development of detection methods for equine anti-doping enforcement. It serves primarily as a research tool for understanding mu-opioid receptor pharmacology and the evolution of bioactive peptides in amphibian defense secretions.
Key Published Findings
Binding studies demonstrate that dermorphin has exceptionally high selectivity and affinity for mu-opioid receptors (Ki approximately 0.2-1.6 nM), significantly exceeding morphine in both potency and selectivity. The D-alanine residue at position 2 confers resistance to aminopeptidase degradation, extending its biological half-life compared to L-amino acid-containing endogenous opioid peptides. Research on dermorphin and its analogs has contributed significantly to understanding structure-activity relationships at the mu-opioid receptor and has led to development of several research tools for opioid pharmacology.
Safety Profile
As an extremely potent mu-opioid agonist, dermorphin carries all the risks associated with opioid intoxication including respiratory depression, profound sedation, physical dependence, and potentially fatal overdose. No therapeutic index has been established for humans, and the steep dose-response curve of highly potent opioids makes accidental overdose a significant risk. The absence of human pharmacokinetic data means that dosing, onset, duration, and drug interactions are completely unknown in clinical contexts.
Comparison to Related Compounds
Dermorphin is significantly more potent than morphine (30-40x) and fentanyl-like in its receptor binding affinity, though it maintains high mu-selectivity unlike some synthetic opioids that have broader receptor profiles. Its natural analog deltorphin (from the same frog species) is similarly potent but selective for delta-opioid receptors rather than mu-receptors. Compared to endogenous opioid peptides (endorphins, enkephalins), dermorphin's D-amino acid content provides superior metabolic stability and greater pharmacological potency.
Community Observations
Dermorphin is primarily known in the public sphere through horse racing scandals, where it has been detected in post-race urine samples from winning horses in multiple US states including Louisiana, Oklahoma, and New Jersey. Its use in horse racing is considered animal abuse by regulatory bodies, as it masks pain and allows injured horses to race at risk of catastrophic breakdown. Human recreational use is extremely rare due to limited availability and the extreme danger posed by its potency, with the research community treating it primarily as a pharmacological tool rather than a potential therapeutic.
半衰期
~2-3 hours
复溶
Sterile saline
存储
冻干
Store at -20C.
复溶后
Refrigerate 2-8C. Use within 7 days.
美国法律状态
又称作
常见问题
什么是 Dermorphin?
Dermorphin is a naturally occurring seven-amino acid opioid peptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) first isolated from the skin secretions of South American tree frogs of the genus Phyllomedusa. It is approximately 30-40 times more potent than morphine as a mu-opioid receptor agonist and contains the unusual D-alanine residue at position 2, making it one of the first discovered naturally occurring D-amino acid-containing peptides. It has gained notoriety for its illegal use in horse racing as a performance enhancer and pain masking agent.
Dermorphin 如何起作用?
Naturally occurring heptapeptide isolated from the skin of South American tree frogs (Phyllomedusa). Potent and selective mu-opioid receptor agonist — approximately 30-40 times more potent than morphine. Contains D-alanine, which is rare in natural peptides.
Dermorphin 在美国的监管状态是什么?
Not scheduled but DEA analog act may apply
Dermorphin 的半衰期是多少?
~2-3 hours
Dermorphin 还有哪些名称?
Dermorph
Peptide Contacts仅提供基于研究的摘要,仅供信息参考。我们不托管、分发或支持供应商文档。所有证书分析、GMP证书和供应商通信必须由买家直接请求并验证。本平台上任何内容均不构成法律、医疗或专业建议。用户在购买任何研究化学品之前应自行核实供应商资质,并确保遵守所有适用的当地、州及联邦法律法规,承担全部法律责任。
阅读完整免责声明